Karuna Therapeutics, Inc.
Compositions and methods for treating disorders ameliorated by muscarinic receptor activation

Abstract:

Provided herein is an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof, and a plurality of trospium beads having a core comprising a salt of trospium.